The estimated Net Worth of Andrew N Schiff is at least $3.73 Million dollars as of 1 June 2024. Andrew Schiff owns over 4,660 units of Aclaris Therapeutics Inc stock worth over $10,817 and over the last 10 years he sold ACRS stock worth over $3,645,748. In addition, he makes $74,916 as Independent Director at Aclaris Therapeutics Inc.
Sign up
Andrew Schiff ACRS stock SEC Form 4 insiders trading
Andrew has made over 13 trades of the Aclaris Therapeutics Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 4,660 units of ACRS stock worth $5,499 on 1 June 2024.
The largest trade he's ever made was buying 1,333,333 units of Aclaris Therapeutics Inc stock on 23 May 2014 worth over $7,999,998. On average, Andrew trades about 84,512 units every 183 days since 2014. As of 1 June 2024 he still owns at least 9,167 units of Aclaris Therapeutics Inc stock.
You can see the complete history of Andrew Schiff stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Andrew Schiff biography
Dr. Andrew N. Schiff M.D. serves as Independent Director of the Company. Dr. Schiff joined Aisling Capital, an investment firm, in September 1999 and currently serves as one of its managing partners. Prior to joining Aisling Capital, Dr. Schiff practiced internal medicine for six years at The New York Presbyterian Hospital, where he maintains his position as a Clinical Assistant Professor of Medicine. Dr. Schiff currently serves as a director of a number of private companies. Within the past five years, he served as a director of the publicly held life sciences companies ZELTIQ Aesthetics, Inc. and Agile Therapeutics, Inc. He is a longtime supporter and board member of the Visiting Nurse Service of New York, as well as other charitable organizations. Dr. Schiff received an M.D. degree from Cornell University Medical College, an M.B.A. degree from Columbia University, and a B.S. degree with honors in Neuroscience from Brown University. Our Board believes that Dr. Schiff’s medical background and venture experience qualify him to serve as a director of our company.
What is the salary of Andrew Schiff?
As the Independent Director of Aclaris Therapeutics Inc, the total compensation of Andrew Schiff at Aclaris Therapeutics Inc is $74,916. There are 11 executives at Aclaris Therapeutics Inc getting paid more, with Neal Walker having the highest compensation of $3,150,020.
How old is Andrew Schiff?
Andrew Schiff is 54, he's been the Independent Director of Aclaris Therapeutics Inc since 2017. There are 6 older and 6 younger executives at Aclaris Therapeutics Inc. The oldest executive at Aclaris Therapeutics Inc is Maxine Gowen, 62, who is the Independent Director.
What's Andrew Schiff's mailing address?
Andrew's mailing address filed with the SEC is C/O ACLARIS THERAPEUTICS, INC., 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087.
Insiders trading at Aclaris Therapeutics Inc
Over the last 9 years, insiders at Aclaris Therapeutics Inc have traded over $101,608,525 worth of Aclaris Therapeutics Inc stock and bought 10,163,038 units worth $66,383,599 . The most active insiders traders include Braden Michael Leonard, Capital Management, Llc Kol..., and Llc Fmr. On average, Aclaris Therapeutics Inc executives and independent directors trade stock every 17 days with the average trade being worth of $111,818. The most recent stock trade was executed by Kevin Balthaser on 1 September 2024, trading 1,000 units of ACRS stock currently worth $1,180.
What does Aclaris Therapeutics Inc do?
aclaris therapeutics, inc. is a dermatologist-led biopharmaceutical company committed to identifying, developing and commercializing innovative therapies to address significant unmet needs in dermatology, both medical and aesthetic, and immunology. aclaris is focused on market segments with no fda-approved medications or where treatment gaps exist. aclaris was founded by dermatologists and is led by a team with extensive experience in developing and commercializing dermatologic treatments.
What does Aclaris Therapeutics Inc's logo look like?
Complete history of Andrew Schiff stock trades at Aclaris Therapeutics Inc and Agile Therapeutics Inc
Aclaris Therapeutics Inc executives and stock owners
Aclaris Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Neal Walker,
President, Chief Executive Officer, Co-Founder, Director -
Kamil Ali-Jackson,
Co-Founder, Chief Compliance Officer, Secretary, Chief Legal Officer -
David Gordon,
Chief Medical Officer -
Frank Ruffo,
Co-Founder, Chief Financial Officer -
Dr. Neal S. Walker D.O.,
Co-Founder, CEO, Pres & Director -
Frank Ruffo,
Co-Founder, CFO & Treasurer -
Christopher Molineaux,
Independent Director -
Bryan Reasons,
Independent Director -
Andrew Powell,
Independent Director -
Anand Mehra,
Independent Director -
William Humphries,
Independent Director -
Andrew Schiff,
Independent Director -
Maxine Gowen,
Independent Director -
Vincent Milano,
Director -
James Loerop,
Chief Bus. Officer -
Dr. Paul S. Changelian Ph.D.,
Sr. VP of Biology -
Spencer Brown J.D.,
Sr. VP of Legal Affairs & Compliance Officer -
Dr. Joseph Monahan,
Chief Scientific Officer -
Rick Bierly,
Director -
Ventures Vii, Llc Vivo Vent...,
-
Stephen A. Tullman,
Director -
Albert Cha,
Director -
Stuart Shanler,
Chief Scientific Officer -
Capital Management, Llc Kol...,
-
Christopher Powala,
Chief Operating Officer -
Llc Fmr,
10% owner -
James E Deerfield Mgmt L.P....,
-
Capital Management Iii, Llc...,
-
Brett Fair,
Chief Commercial Officer -
Capital Management, Llc Kol...,
-
Venture Partners Viii, L.P....,
-
Gail Cawkwell,
Chief Medical Officer -
Joseph Monahan,
Chief Scientific Officer -
Douglas J. Manion,
Pres and CEO -
James Loerop,
Chief Business Officer -
Braden Michael Leonard,
-
Kevin Balthaser,
Chief Financial Officer